Australia approves Kimberly-Clark's acquisition of Kenvue, but requires divestment of Carefree and Stayfree brands
Article excerpt
Highlighted: the sentence this signal was extracted from
((Automated translation by Reuters using machine learning and generative AI, please refer to the following disclaimer: https://bit.ly/rtrsauto)) Australia's competition authority on Wednesday approved Kimberly-Clark's KMB.O proposed $40 billion acquisition of Kenvue KVUE.N, on condition that the company divest Kenvue's Carefree and Stayfree feminine hygiene brands in the Australian market to address competition concerns. Here are the details: * The Australian Competition and Consumer Commission (ACCC) said these brands must be divested to an approved acquirer. * The regulator explained that, without this divestment, the transaction risked weakening competition in the feminine hygiene sector, as both companies are among the three main suppliers of feminine hygiene products in Australia. * The deal, announced in November, would allow Kimberly-Clark to acquire Kenvue's well-known global brands, such as Listerine mouthwash and Neutrogena, but would expose the company to the lawsuits Kenvue faces regarding Tylenol. * Kimberly-Clark has also sought approval from EU regulators for the acquisition, as documents published on the European Commission's website last week revealed. * "This divestment will preserve an independent competitor in the Australian feminine hygiene products market and maintain competition that would otherwise be lost as a result of the acquisition," said Philip...
Keep reading with a free account
The rest of this article, and every signal for Kenvue, is in your free account.
